Goodwill and Other Intangible Assets (Product Rights and License by Therapeutic Category) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		$ 6,484.2	$ 1,598.2
Product rights and licenses
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		$ 6,195.9	$ 1,489.2
Therapeutic class disclosure threshold		5.00%	5.00%
Product rights and licenses | Allergy
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		$ 71.2	$ 82.5
Product rights and licenses | Anti-infectives
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		368.7	152.8
Product rights and licenses | Antineoplastic
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		169.3	123.7
Product rights and licenses | Cardiovascular
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		1,105.5	175.0
Product rights and licenses | Central Nervous System
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		949.8	199.5
Product rights and licenses | Dermatological
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		52.9	65.9
Product rights and licenses | Endocrine and Metabolic
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		1,152.5	54.8
Product rights and licenses | Gastrointestinal
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		1,289.9	67.6
Product rights and licenses | Hematological Agents
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		370.1	294.5
Product rights and licenses | Immunological Agents
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		322.7	20.8
Product rights and licenses | Respiratory System
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net		137.9	78.3
Product rights and licenses | Other
Schedule of Product Rights and Licenses by Therapeutic Class [Line Items]
Finite-lived intangible assets, net	[1]	$ 205.4	$ 173.8

[1] Other consists of numerous therapeutic classes, none of which individually exceeds 5% of total product rights and licenses.